PKM and metabolic dysfunction-associated steatotic liver disease: In addition, PKM2 is identified as a major celastrol-bound protein, and celastrol binds to the residue Cys31 and further alters the spatial conformation to reduce the enzyme activity of PKM2 in hepatic macrophages against non-alcoholic fatty liver disease (Fan et al., 2022).